Human Genetic Signatures has elected to make their recent Journal of Commercial Biotechnology paper open access through the JCB’s Open Access Option. By electing for open access, the paper is now free to read without subscription.
For more on their assessment of the Microsoft vs. Apple ‘black-box’ model for diagnostic testing, see their paper:
What do hospital labs really need to streamline diagnostic testing: Apple vs. Microsoft environment?